Analysis of inhibitor of apoptosis protein family expression during mammary gland development

BMC Developmental Biology

Volumn 10, Issue , 2010, Pages

  Owens, Thomas W ^a   Foster, Fiona M ^a   Tanianis Hughes, Jolanta ^a   Cheung, Julia Y ^a   Brackenbury, Lisa ^a   Streuli, Charles H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTRACISTERNAL A-PARTICLES; MAMMALIA;

INHIBITOR OF APOPTOSIS PROTEIN;

ANIMAL; ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE; PREGNANCY; UDDER;

ANIMALS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INHIBITOR OF APOPTOSIS PROTEINS; MAMMARY GLANDS, ANIMAL; MICE; PREGNANCY;

EID: 77953946920     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-10-71     Document Type: Article

References (46)

1. Anoikis. AP Gilmore, Cell Death Differ 2005 12 Suppl 2 1473 7 10.1038/sj.cdd.4401723 16247493
2. Integrin-regulated FAK-Src signaling in normal and cancer cells. SK Mitra DD Schlaepfer, Curr Opin Cell Biol 2006 18 516 23 10.1016/j.ceb.2006.08.011 16919435
3. Microarray analysis of the involution switch. RW Clarkson CJ Watson, J Mammary Gland Biol Neoplasia 2003 8 309 19 10.1023/B:JOMG.0000010031.53310.92 14973375
4. Apoptosis and mammary gland involution: reviewing the process. PA Furth U Bar-Peled M Li, Apoptosis 1997 2 19 24 10.1023/A:1026454207398 14646561
5. Apoptosis regulation in the mammary gland. KA Green CH Streuli, Cell Mol Life Sci 2004 61 1867 83 10.1007/s00018-004-3366-y 15289930
6. Mammary involution and breast cancer risk: transgenic models and clinical studies. DC Radisky LC Hartmann, J Mammary Gland Biol Neoplasia 2009 14 181 91 10.1007/s10911-009-9123-y 19404726
7. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. M Santisteban JM Reiman MK Asiedu MD Behrens A Nassar KR Kalli P Haluska JN Ingle LC Hartmann MH Manjili, et al. Cancer Res 2009 69 2887 95 10.1158/0008-5472.CAN-08-3343 19276366
8. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. FL Scott JB Denault SJ Riedl H Shin M Renatus GS Salvesen, Embo J 2005 24 645 55 10.1038/sj.emboj.7600544 15650747
9. Diverse functions within the IAP family. JM Rumble CS Duckett, J Cell Sci 2008 121 3505 7 10.1242/jcs.040303 18946021
10. IAPs, RINGs and ubiquitylation. DL Vaux J Silke, Nat Rev Mol Cell Biol 2005 6 287 97 10.1038/nrm1621 15803136
11. IAP proteins: blocking the road to death's door. GS Salvesen CS Duckett, Nat Rev Mol Cell Biol 2002 3 401 10 10.1038/nrm830 12042762
12. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. T Tenev A Zachariou R Wilson M Ditzel P Meier, Nat Cell Biol 2005 7 70 7 10.1038/ncb1204 15580265
13. Mammalian mitochondrial IAP binding proteins. DL Vaux J Silke, Biochem Biophys Res Commun 2003 304 499 504 10.1016/S0006-291X(03)00622-3 12729584
14. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. J Silke T Kratina D Chu PG Ekert CL Day M Pakusch DC Huang DL Vaux, Proc Natl Acad Sci USA 2005 102 16182 7 10.1073/pnas.0502828102 16263936
15. Cytoprotective effects of IAPs revealed by a small molecule antagonist. S Galban C Hwang JM Rumble KA Oetjen CW Wright A Boudreault J Durkin JW Gillard JB Jaquith SJ Morris, et al. Biochem J 2009 417 765 71 10.1042/BJ20081677 18851715
16. The inhibitors of apoptosis (IAPs) as cancer targets. AM Hunter EC LaCasse RG Korneluk, Apoptosis 2007 12 1543 68 10.1007/s10495-007-0087-3 17573556
17. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. L Yang Z Cao H Yan WC Wood, Cancer Res 2003 63 6815 24 14583479
18. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer. FM Foster TW Owens J Tanianis-Hughes RB Clarke K Brennan NJ Bundred CH Streuli, Breast Cancer Res 2009 11 41 10.1186/bcr2328 19563669
19. Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland. AD Metcalfe A Gilmore T Klinowska J Oliver AJ Valentijn R Brown A Ross G MacGregor JA Hickman CH Streuli, J Cell Sci 1999 112 Pt 11 1771 83 10318769
20. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. LR Lund J Romer N Thomasset H Solberg C Pyke MJ Bissell K Dano Z Werb, Development 1996 122 181 93 8565829
21. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. RS Chapman PC Lourenco E Tonner DJ Flint S Selbert K Takeda S Akira AR Clarke CJ Watson, Genes Dev 1999 13 2604 16 10.1101/gad.13.19.2604 10521404
22. Mechanisms of caspase activation and inhibition during apoptosis. Y Shi, Mol Cell 2002 9 459 70 10.1016/S1097-2765(02)00482-3 11931755
23. Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors. B Blackman T Russell SK Nordeen D Medina MC Neville, Breast Cancer Res 2005 7 248 55 10.1186/bcr988 15743505
24. ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. NG Anderson T Ahmad K Chan R Dobson NJ Bundred, Int J Cancer 2001 94 774 82 10.1002/ijc.1557 11745477
25. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. AP Gilmore AJ Valentijn P Wang AM Ranger N Bundred MJ O'Hare A Wakeling SJ Korsmeyer CH Streuli, J Biol Chem 2002 277 27643 50 10.1074/jbc.M108863200 12011069
26. Bim is an apoptosis sensor that responds to loss of survival signals delivered by epidermal growth factor but not those provided by integrins. P Wang AP Gilmore CH Streuli, J Biol Chem 2004 279 41280 5 10.1074/jbc.C400248200 15292207
27. Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38MAPK. TW Owens AJ Valentijn JP Upton J Keeble L Zhang J Lindsay NK Zouq AP Gilmore, Cell Death Differ 2009 16 1551 62 10.1038/cdd.2009.102 19662026
28. Apoptotic sensitivity of murine IAP-deficient cells. JM Rumble MJ Bertrand RA Csomos CW Wright L Albert TW Mak PA Barker CS Duckett, Biochem J 2008 415 21 5 10.1042/BJ20081188 18684108
29. X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development. A Gruslin Q Qiu BK Tsang, Biol Reprod 2001 64 1264 72 10.1095/biolreprod64.4.1264 11259275
30. Motoneuron resistance to apoptotic cell death in vivo correlates with the ratio between X-linked inhibitor of apoptosis proteins (XIAPs) and its inhibitor, XIAP-associated factor 1. D Perrelet FE Perrin P Liston RG Korneluk A MacKenzie M Ferrer-Alcon AC Kato, J Neurosci 2004 24 3777 85 10.1523/JNEUROSCI.0413-04.2004 15084658
31. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. CJ Watson WT Khaled, Development 2008 135 995 1003 10.1242/dev.005439 18296651
32. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. RW Clarkson MT Wayland J Lee T Freeman CJ Watson, Breast Cancer Res 2004 6 92 109 10.1186/bcr754 14979921
33. Roles of Fas and Fas ligand during mammary gland remodeling. J Song E Sapi W Brown J Nilsen K Tartaro BM Kacinski J Craft F Naftolin G Mor, J Clin Invest 2000 106 1209 20 10.1172/JCI10411 11086022
34. X chromosome-linked inhibitor of apoptosis regulates cell death induction by proapoptotic receptor agonists. E Varfolomeev B Alicke JM Elliott K Zobel K West H Wong JM Scheer A Ashkenazi SE Gould WJ Fairbrother, et al. J Biol Chem 2009 284 34553 60 10.1074/jbc.M109.040139 19854829
35. XIAP discriminates between type I and type II FAS-induced apoptosis. PJ Jost S Grabow D Gray MD McKenzie U Nachbur DC Huang P Bouillet HE Thomas C Borner J Silke, et al. Nature 2009 460 1035 9 10.1038/nature08229 19626005
36. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. JE Vince WW Wong N Khan R Feltham D Chau AU Ahmed CA Benetatos SK Chunduru SM Condon M McKinlay, et al. Cell 2007 131 682 93 10.1016/j.cell.2007.10.037 18022363
37. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. E Varfolomeev JW Blankenship SM Wayson AV Fedorova N Kayagaki P Garg K Zobel JN Dynek LO Elliott HJ Wallweber, et al. Cell 2007 131 669 81 10.1016/j.cell.2007.10.030 18022362
38. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). S Kaur F Wang M Venkatraman M Arsura, J Biol Chem 2005 280 38599 608 10.1074/jbc.M505671200 16157589
39. NF-kappaB inhibits apoptosis in murine mammary epithelia. RW Clarkson JL Heeley R Chapman F Aillet RT Hay A Wyllie CJ Watson, J Biol Chem 2000 275 12737 42 10.1074/jbc.275.17.12737 10777569
40. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. M Lu SC Lin Y Huang YJ Kang R Rich YC Lo D Myszka J Han H Wu, Mol Cell 2007 26 689 702 10.1016/j.molcel.2007.05.006 17560374
41. The mammary gland epithelial cell. S Pullan CH Streuli, Epithelial cell culture Cambridge: Cambridge University Press, Harris A, 1996 97 121
42. Adipose-depleted mammary epithelial cells and organoids. MC Rudolph EA Wellberg SM Anderson, J Mammary Gland Biol Neoplasia 2009 14 381 6 10.1007/s10911-009-9161-5 19953310
43. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. S Pullan J Wilson A Metcalfe GM Edwards N Goberdhan J Tilly JA Hickman C Dive CH Streuli, J Cell Sci 1996 109 Pt 3 631 42 8907708
44. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. FS Kittrell CJ Oborn D Medina, Cancer Res 1992 52 1924 32 1372532
45. Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice. FJ Alarcon-Aguilar J Almanza-Perez G Blancas S Angeles R Garcia-Macedo R Roman M Cruz, Eur J Pharmacol 2008 599 152 8 18930730
46. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover. ZH Huang CA Reardon T Mazzone, Diabetes 2006 55 3394 402 10.2337/db06-0354 17130485